DocSym
β
Searchsearch
Search
(C96.9) Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
More details coming soon
123 676 in individuals diagnosis malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified confirmed
37 151 deaths with diagnosis malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
30% mortality rate associated with the disease malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
Diagnosis malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified is diagnosed Men are 17.09% more likely than Women
72 407
Men receive the diagnosis malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
17 751 (24.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
51 269
Women receive the diagnosis malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
19 400 (37.8 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified - Men aged 75-79 and Women aged 70-74
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
Absence or low individual and public risk
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified - what does this mean
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified is a type of cancer that arises from abnormal cells in the lymphatic system, blood, and other tissues related to the immune system. these cells can grow and divide uncontrollably, leading to a tumor that can spread to other parts of the body.
What happens during the disease - malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
The pathogenesis of malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified is not well understood, but is thought to involve a combination of genetic, environmental, and lifestyle factors that lead to an uncontrolled growth of abnormal cells in the lymphoid, haematopoietic, and related tissues. this abnormal cell growth can lead to the formation of tumors, which can then spread to other parts of the body.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Complete blood count
- CT Scan
- X-ray
- PET Scan
- Biopsy
- Bone marrow aspiration
- Lumbar puncture
- Immunophenotyping
- Flow cytometry
- Cytogenetic analysis
Treatment and Medical Assistance
Main goal: Treat the malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified.
- Surgery to remove the tumor
- Radiation therapy to target cancer cells
- Chemotherapy to kill cancer cells
- Immunotherapy to boost the immune system
- Targeted therapy to target specific cancer cells
- Stem cell transplant to replace damaged cells
- Clinical trials to test new treatments
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified - Prevention
The best way to prevent malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified is to practice healthy lifestyle habits such as maintaining a healthy weight, avoiding smoking, limiting alcohol intake, eating a balanced diet, and getting regular exercise. additionally, it is important to get regular check-ups and screenings to detect any early signs of the disease.